(Q40881209)

24 September 2017

title

Levamisole in the Treatment of Non-invasive and Invasive Bladder Cancer: A Preliminary Report (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57487-X

3 April 2023

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57487-X

3 April 2023

author name string

R. B. Smith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A347106

3 April 2023

J. Dekernion

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A347106

3 April 2023

B. Baron

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A347106

3 April 2023

D. G. Skinner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A347106

3 April 2023

J. J. Kaufman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A347106

3 April 2023

language of work or name

English

0 references

publication date

1 March 1978

1 reference

full work available at URL

24 September 2017

https://api.elsevier.com/content/article/PII:S002253471757487X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57487-X

https://api.elsevier.com/content/article/PII:S002253471757487X?httpAccept=text/plain

3 April 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57487-X

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2957487-X

3 April 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57487-X

3 April 2023

1 reference

24 September 2017

volume

119

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

347-349

1 reference

Drug-Induced Restoration of Cutaneous Delayed Hypersensitivity in Anergic Patients with Cancer

24 September 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57487-X

Letter: In-vitro resotration by levamisole of thymus-derived lymphocyte function in Hodgkin's disease

3 April 2023

4

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57487-X

Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma

3 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57487-X

Double-blind levamisole trial in resectable lung cancer

3 April 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57487-X

Levamisole in advanced human breast cancer

3 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57487-X

Prognostic Value of Host Immunocompetence in Urologic Cancer Patients

3 April 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57487-X

Immune evaluation with skin testing. A study of testicular, prostatic, and bladder neoplasms

3 April 2023

12

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57487-X

Immunologic unreactivity in bladder cancer patients

3 April 2023

13

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57487-X

Immune Reactivity in Renal Cancer: A Sequential Study

3 April 2023

14

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57487-X

Lymphocytes and bladder cancer

3 April 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57487-X

Lymphocytopenia: its causes and significance

3 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57487-X

Abnormal Monocyte Function in Bladder Cancer Patients

3 April 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57487-X

3 April 2023

Identifiers

0 references

1 reference